TP53 and cancer: The results indicated enrichment of multiple metabolic pathways, including fatty acid metabolism, glycerolipid metabolism and beta alanine metabolism in cluster A, while cluster B exhibited enrichment in multiple pro-cancer pathways, such as the P53 signaling pathway (Figure 1E).